Clinical Report: Association of UGT1A1 Genetic Variants with Hyperbilirubinemia
Overview
This study investigates the association between UGT1A1 genetic variants identified through newborn genetic screening and the occurrence of neonatal hyperbilirubinemia. Certain UGT1A1 variants were linked to mildly elevated total bilirubin levels at 6 weeks.
Background
Neonatal hyperbilirubinemia is a common condition that can lead to serious health issues if not managed properly. Genetic screening for UGT1A1 variants may provide insights into the risk of developing hyperbilirubinemia.
Data Highlights
Group
Number of Newborns
Mean TcB on Day 42
Hom
45
Higher than controls
CH
26
Higher than controls
3 loci
4
Highest values
Controls
40
Reference
Key Findings
75 newborns had confirmed biallelic or multi-allelic UGT1A1 variants.
Common variants included c.211G>A and c.-41_-40dup.
TcB levels were higher in mutation groups compared to controls on day 42 (P < 0.001).
Clinically significant hyperbilirubinemia was rare, with only four cases documented.
Clinical Implications
The study indicates that UGT1A1 variants may lead to elevated bilirubin levels, but do not correlate with severe hyperbilirubinemia requiring intervention.
Conclusion
The association of UGT1A1 variants with bilirubin levels suggests careful interpretation of genetic screening results in newborns.
